Health & Fitness
Tue, July 24, 2012Mon, July 23, 2012Sun, July 22, 2012Sat, July 21, 2012Fri, July 20, 2012Thu, July 19, 2012Wed, July 18, 2012Tue, July 17, 2012Mon, July 16, 2012Fri, July 13, 2012Thu, July 12, 2012Wed, July 11, 2012Tue, July 10, 2012Mon, July 9, 2012Fri, July 6, 2012Thu, July 5, 2012Wed, July 4, 2012Tue, July 3, 2012Mon, July 2, 2012Sun, July 1, 2012Fri, June 29, 2012Thu, June 28, 2012Cytomedix, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
Published in Health and Fitness on Tuesday, July 10th 2012 at 13:51 GMT by Market Wire
Cytomedix, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th -- NEW YORK, July 10, 2012 /PRNewswire/ --
Cytomedix, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference
NEW YORK, July 10, 2012 /PRNewswire/ -- Cytomedix, Inc. (OTC: CMXI), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies for wound and tissue repair, announced that Martin P. Rosendale, Chief Executive Officer, will present at RetailInvestorConferences.com.
DATE: | July 12, 2012 |
TIME: | 11:00 AM EDT |
LINK: | [ www.retailinvestorconferences.com ]> red "register / watch event now" button |
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register to save time and receive event updates.
About Cytomedix, Inc.
Cytomedix, Inc. is an autologous regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies for wound and tissue repair. The Company markets the AutoloGel™ System, a device for the production of autologous platelet rich plasma ("PRP") gel for use on a variety of exuding wounds and the Angel® Whole Blood Separation System, a blood processing device and disposable products used for the separation of whole blood into red cells, platelet poor plasma ("PPP") and PRP in surgical settings On February 8, 2012 Cytomedix closed the acquisition of Aldagen, a biopharmaceutical company developing regenerative cell therapies based on its proprietary ALDH bright cell ("ALDHbr") technology, currently in a Phase 2 trial for the treatment of ischemic stroke. For additional information please visit [ www.cytomedix.com ].
About RetailInvestorConferences.com
Since 2010, RetailInvestorConferences.com, created by [ BetterInvesting (NAIC) ][ PR Newswire ] and [ MUNCmedia ], has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.
SOURCE Cytomedix, Inc.
[ Back to top ]
RELATED LINKS
[ http://www.retailinvestorconferences.com ]
[ http://www.cytomedix.com ]
